Stay updated on Revvity Press Releases
Sign up to get notified when there's something new on the Revvity Press Releases page.
Latest updates to the Revvity Press Releases page
- Check3 days agoChange DetectedRevvity has announced FDA clearance for its first automated free testosterone test, while a previously scheduled earnings call for November 4, 2024, has been removed from the press releases.SummaryDifference19%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevvity, Inc. will present at the upcoming J.P. Morgan Healthcare Conference on December 17, 2024, while a previous press release regarding their EUROIMMUN solution for Alzheimer's disease genotyping has been removed.SummaryDifference19%
- Check32 days agoNo Change Detected
- Check53 days agoChange DetectedRevvity has expanded its collaboration with Genomics England to enhance genomics in the UK and will host an Investor Day on November 21, 2024, while notable deletions include previous announcements about upcoming investor conferences and financial results.SummaryDifference100%
- Check68 days agoChange DetectedRevvity has announced its financial results for Q3 2024, reporting a revenue of $684 million with 2% growth, while a previous announcement regarding their presentation at the Goldman Sachs Global Healthcare Conference has been removed.SummaryDifference21%
- Check82 days agoChange DetectedRevvity, Inc. has declared a quarterly dividend and introduced Transcribe AI for clinical data entry, while also releasing its 2024 Impact Report focusing on sustainability and workplace culture.SummaryDifference100%
- Check97 days agoChange DetectedRevvity has announced an upcoming earnings call on November 4, 2024, while a previous press release regarding a newborn screening study has been removed.SummaryDifference20%
Stay in the know with updates to Revvity Press Releases
Enter your email address, and we'll notify you when there's something new on the Revvity Press Releases page.